Pulse Biosciences

Pulse Biosciences EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Pulse Biosciences (PLSE) as of Nov 2, 2026 is -76.94 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -56.26 M USD — a change of 36.76% (lower).

EBITDA

-76.94 MUSD

YoY

36.76%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Pulse Biosciences is 2025 -76.94 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Pulse Biosciences was 2024 -56.26 M USD. It decreases by 36.76% lower compared to the previous year.

The Pulse Biosciences EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-37.29 M USD
Jan 1, 2019
-47.28 M USD
Jan 1, 2020
-49.30 M USD
Jan 1, 2021
-63.01 M USD
Jan 1, 2022
-58.06 M USD
Jan 1, 2023
-43.57 M USD
Jan 1, 2024
-56.26 M USD
Jan 1, 2025
-76.94 M USD
The Pulse Biosciences EBITDA history
YEAREBITDAYoY
-76.94 MUSD+36.76%
-56.26 MUSD+29.11%
-43.57 MUSD-24.95%
-58.06 MUSD-7.87%
-63.01 MUSD+27.83%
-49.30 MUSD+4.25%
-47.28 MUSD+26.79%
-37.29 MUSD+48.32%
-25.14 MUSD+182.01%
-8.92 MUSD+134.76%
-3.80 MUSD+1,812.64%
-198,571.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pulse Biosciences Stock analysis

What does Pulse Biosciences do? Pulse Biosciences Inc. is a US-based company specializing in the development of groundbreaking medical technologies. Founded in 2014 and headquartered in Hayward, California, the company has made impressive progress by introducing a variety of products and technologies that have excited medical experts worldwide. Pulse Biosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulse Biosciences stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Pulse Biosciences is -76.94 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Pulse Biosciences changed from -56.26 M USD to -76.94 M USD, representing a 36.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Pulse Biosciences since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Pulse Biosciences historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Pulse Biosciences

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Pulse Biosciences